Two Sigma Advisers
ETON icon

Two Sigma Advisers’s Eton Pharmaceutcials ETON Stock Holding History

Two Sigma Advisers’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,700
Closed -$249K – 709
2025
Q4 		$249K Sell
14,700
-154,200
-91% -$2.71M ﹤0.01% 2041
2025
Q3 		$3.67M Buy
168,900
+68,000
+67% +$1.13M 0.01% 860
2025
Q2 		$1.44M Buy
100,900
+47,800
+90% +$756K ﹤0.01% 1273
2025
Q1 		$689K Buy
53,100
+3,400
+7% +$51.4K ﹤0.01% 1643
2024
Q4 		$662K Buy
+49,700
New +$504K ﹤0.01% 1660
2024
Q2 		– Sell
-17,700
Closed -$66.4K – 2511
2024
Q1 		$66.4K Buy
17,700
+6,800
+62% +$29.7K ﹤0.01% 2332
2023
Q4 		$47.7K Buy
+10,900
New +$43.7K ﹤0.01% 2402
2021
Q2 		– Sell
-36,900
Closed -$270K – 2516
2021
Q1 		$270K Buy
36,900
+23,100
+167% +$197K ﹤0.01% 2259
2020
Q4 		$112K Buy
+13,800
New +$106K ﹤0.01% 2257

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Two Sigma Advisers's ETON Position: Q1 2026 in Review

Two Sigma Advisers sold out of Eton Pharmaceutcials (ETON) in Q1 2026, closing a stake of 14,700 shares — an estimated $249K sold.

Two Sigma Advisers first reported a position in ETON in Q4 2020 and held it in 9 quarters. The position peaked at $3.67M in Q3 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Two Sigma Advisers reported no remaining Eton Pharmaceutcials position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 14,700 Eton Pharmaceutcials shares in Q1 2026, an estimated $249K.
  • Two Sigma Advisers first reported a position in Eton Pharmaceutcials in Q4 2020 and held it in 9 quarters.
  • Two Sigma Advisers's Eton Pharmaceutcials position peaked at $3.67M in Q3 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.